Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rozlytrek from Roche gets EC approval to treat solid tumours and NSCLC

expresspharmaAugust 04, 2020

Tag: Rozlytrek , Roche , NSCLC , tumours

PharmaSources Customer Service